Results

Viatris Inc.

07/28/2021 | Press release | Distributed by Public on 07/28/2021 21:33

Viatris Inc. and Biocon Biologics Receive Historic Approval for First Interchangeable Biosimilar Semglee® (insulin glargine-yfgn injection) for the Treatment of Diabetes